Skip to main content
Erschienen in: The European Journal of Health Economics 3/2015

01.04.2015 | Original Paper

Transforming EQ-5D utilities for use in cost–value analysis of health programs

verfasst von: Erik Nord, Rune Johansen

Erschienen in: The European Journal of Health Economics | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

In a number of jurisdictions there is increasing interest in incorporating concerns for fairness in models for economic evaluation of health interventions. Cost–value analysis is a name for evaluations with such a broader aim. The most widely held concern for fairness is a concern for the worse off, i.e. the idea that severity of illness should count in determining priorities. In economic evaluations of improvements in health-related quality of life this concern may be taken into account by replacing conventional health state utilities with societal values for health states that are characterised by strong upper end compression and decreasing marginal value of utility gains. We review evidence on the strength of concerns for the worse off—measured at the cardinal level—in 15 articles published in peer-reviewed journals in the time period 1978–2010, with reports from altogether 20 individual studies in nine different countries. We report 116 individual observations of paired comparisons of utility improvements with different start levels. Concerns for severity show up quite strongly across countries, sample types and question framings. By means of regression analyses we fit a societal value function to the data that has the property of decreasing marginal value of utility gains. Using the central tendency in the data we present two plausible transformations of EQ-5D utilities into societal values that reflect concerns for the worse off.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Drummond, M., Brixner, D., Gold, M., Kind, P., McGuire, A., Nord, E.: Toward a consensus on the QALY. Value Health 12(Supplement 1), S31–S35 (2009)CrossRefPubMed Drummond, M., Brixner, D., Gold, M., Kind, P., McGuire, A., Nord, E.: Toward a consensus on the QALY. Value Health 12(Supplement 1), S31–S35 (2009)CrossRefPubMed
2.
Zurück zum Zitat Norwegian Commission for Prioritising in Health Care. Retningslinjer for prioritering innen helsevesenet. (Guidelines for prioritising in health care). NOU 1987:23. Oslo: Universitetsforlaget (1987) Norwegian Commission for Prioritising in Health Care. Retningslinjer for prioritering innen helsevesenet. (Guidelines for prioritising in health care). NOU 1987:23. Oslo: Universitetsforlaget (1987)
3.
Zurück zum Zitat Dutch Government Committee on Choices in Health Care: Choices in health care. Ministry of Welfare, Health and Cultural Affairs, Rijswijk (1992) Dutch Government Committee on Choices in Health Care: Choices in health care. Ministry of Welfare, Health and Cultural Affairs, Rijswijk (1992)
4.
Zurück zum Zitat Swedish Health Care and Medical Priorities Commission. No easy choices. SOU 1993:93. Stockholm: Ministry of Health and Social Affairs (1993) Swedish Health Care and Medical Priorities Commission. No easy choices. SOU 1993:93. Stockholm: Ministry of Health and Social Affairs (1993)
5.
Zurück zum Zitat Campbell, A., Gillett, G.: Justice and the right to health care. In Ethical Issues in Defining Core Services. Wellington: The National Advisory Committee on Core Health and Disability Support Services (1993) Campbell, A., Gillett, G.: Justice and the right to health care. In Ethical Issues in Defining Core Services. Wellington: The National Advisory Committee on Core Health and Disability Support Services (1993)
6.
Zurück zum Zitat Nord, E.: Severity of illness versus expected benefit in societal evaluation of healthcare interventions. Exp. Rev. Pharmacoecon. Outcomes Res. 1, 85–92 (2001)CrossRef Nord, E.: Severity of illness versus expected benefit in societal evaluation of healthcare interventions. Exp. Rev. Pharmacoecon. Outcomes Res. 1, 85–92 (2001)CrossRef
7.
Zurück zum Zitat Dolan, P., Shaw, R., Tsuchiya, A., Williams, A.: QALY-maximisation and people’s preferences: a methodological review of the literature. Health Econ. 14, 197–208 (2005)CrossRefPubMed Dolan, P., Shaw, R., Tsuchiya, A., Williams, A.: QALY-maximisation and people’s preferences: a methodological review of the literature. Health Econ. 14, 197–208 (2005)CrossRefPubMed
8.
Zurück zum Zitat Shah, K.: Severity of illness and priority setting in health care: a review of the literature. Health Policy 93, 77–84 (2009)CrossRefPubMed Shah, K.: Severity of illness and priority setting in health care: a review of the literature. Health Policy 93, 77–84 (2009)CrossRefPubMed
9.
Zurück zum Zitat Norwegian Medicine Agency. Guidelines for pharmacoeconomic evaluations. Oslo (2002) Norwegian Medicine Agency. Guidelines for pharmacoeconomic evaluations. Oslo (2002)
10.
Zurück zum Zitat Van de Wetering, E.J., Stolk, E.A., van Exel, N.J.A., Brouwer, W.B.F.: Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. Eur. J. Health Econ. 14, 107–115 (2013)CrossRefPubMedCentralPubMed Van de Wetering, E.J., Stolk, E.A., van Exel, N.J.A., Brouwer, W.B.F.: Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. Eur. J. Health Econ. 14, 107–115 (2013)CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Department of Health.: A new value-based approach to the pricing of branded medicines. Government response to consultation. London (2011) Department of Health.: A new value-based approach to the pricing of branded medicines. Government response to consultation. London (2011)
12.
Zurück zum Zitat Nord, E.: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy 24, 227–238 (1993)CrossRefPubMed Nord, E.: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy 24, 227–238 (1993)CrossRefPubMed
13.
Zurück zum Zitat Nord, E.: Cost-value analysis in health care. Cambridge University Press, Cambridge (1999) Nord, E.: Cost-value analysis in health care. Cambridge University Press, Cambridge (1999)
14.
Zurück zum Zitat Williams, A.: Ethics and efficiency in the provision of health care. In: Bell, J.M., Mendus, S. (eds.) Philosophy and medical welfare. Cambridge University Press, Cambridge (1988) Williams, A.: Ethics and efficiency in the provision of health care. In: Bell, J.M., Mendus, S. (eds.) Philosophy and medical welfare. Cambridge University Press, Cambridge (1988)
15.
Zurück zum Zitat Williams, A.: Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ. 6, 117–132 (1997)CrossRefPubMed Williams, A.: Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ. 6, 117–132 (1997)CrossRefPubMed
16.
Zurück zum Zitat Nord, E., Johansen, R.: Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. doi:10.1016/j.healthpol.2014.02.009 (2014) Nord, E., Johansen, R.: Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. doi:10.​1016/​j.​healthpol.​2014.​02.​009 (2014)
17.
Zurück zum Zitat Nord, E., Pinto, J.L., Richardson, J., Menzel, P., Ubel, P.: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ. 8, 25–39 (1999)CrossRefPubMed Nord, E., Pinto, J.L., Richardson, J., Menzel, P., Ubel, P.: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ. 8, 25–39 (1999)CrossRefPubMed
18.
Zurück zum Zitat Elvik, R.: The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc. Sci. Med. 40, 1385–1398 (1995)CrossRefPubMed Elvik, R.: The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc. Sci. Med. 40, 1385–1398 (1995)CrossRefPubMed
19.
Zurück zum Zitat Nord, E., Wisløff, F., Hjorth, M., Westin, J.: Cost-utility analysis of melphalan plus prednisone with or without interferon-α2b in newly diagnosed multiple myeloma. Pharmacoeconomics 12, 89–103 (1997)CrossRefPubMed Nord, E., Wisløff, F., Hjorth, M., Westin, J.: Cost-utility analysis of melphalan plus prednisone with or without interferon-α2b in newly diagnosed multiple myeloma. Pharmacoeconomics 12, 89–103 (1997)CrossRefPubMed
20.
Zurück zum Zitat Nord, E., Dalgard, O.S.: Economic evaluation of course in coping with depression. J. Nor. Med. Assoc. 126, 586–588 (2006). (text in Norwegian) Nord, E., Dalgard, O.S.: Economic evaluation of course in coping with depression. J. Nor. Med. Assoc. 126, 586–588 (2006). (text in Norwegian)
21.
Zurück zum Zitat Williams, A.: The measurement and valuation of health: a chronicle. Discussion paper 136. Centre for Health Economics. York: The University of York (1995) Williams, A.: The measurement and valuation of health: a chronicle. Discussion paper 136. Centre for Health Economics. York: The University of York (1995)
22.
Zurück zum Zitat Dolan, P.: The measurement of individual utility and social welfare. J. Health Econ. 17, 39–52 (1998)CrossRefPubMed Dolan, P.: The measurement of individual utility and social welfare. J. Health Econ. 17, 39–52 (1998)CrossRefPubMed
23.
Zurück zum Zitat Green, C., Gerard, K.: Exploring the social value of health care interventions: a stated preference discrete choice experiment. Health Econ. 18, 951–976 (2009)CrossRefPubMed Green, C., Gerard, K.: Exploring the social value of health care interventions: a stated preference discrete choice experiment. Health Econ. 18, 951–976 (2009)CrossRefPubMed
24.
Zurück zum Zitat Dolan, P., Edlin, R., Tsuchyia, A., et al.: The relative value of health gains to different beneficiaries. Report to the NIHR and NICE (2008) Dolan, P., Edlin, R., Tsuchyia, A., et al.: The relative value of health gains to different beneficiaries. Report to the NIHR and NICE (2008)
25.
Zurück zum Zitat Goldman, D., Lakdawalla, D., Philipson, T.J., Yin, W.: Valuing health technologies at NICE. Health Econ. 19, 1109–1116 (2010)CrossRefPubMed Goldman, D., Lakdawalla, D., Philipson, T.J., Yin, W.: Valuing health technologies at NICE. Health Econ. 19, 1109–1116 (2010)CrossRefPubMed
26.
Zurück zum Zitat Nord, E.: The social value of a QALY: comments to the final report from the SVQ team. Note submitted to NICE. Oslo: Norwegian Institute of Public Health (2008) Nord, E.: The social value of a QALY: comments to the final report from the SVQ team. Note submitted to NICE. Oslo: Norwegian Institute of Public Health (2008)
27.
Zurück zum Zitat Nord, E.: The validity of a visual analogue scale in determining social utility weights for health states. Int. J. Health Plan Manag. 6, 234–242 (1991)CrossRef Nord, E.: The validity of a visual analogue scale in determining social utility weights for health states. Int. J. Health Plan Manag. 6, 234–242 (1991)CrossRef
28.
Zurück zum Zitat Nord, E., Richardson, J., Macarounas-Kirchman, K.: Societal evaluations of health states. Int. J. Technol. Assess. Health Care 9, 463–478 (1993)CrossRefPubMed Nord, E., Richardson, J., Macarounas-Kirchman, K.: Societal evaluations of health states. Int. J. Technol. Assess. Health Care 9, 463–478 (1993)CrossRefPubMed
29.
Zurück zum Zitat Nord, E.: The person trade-off approach to valuing health care programs. Med. Dec. Making 15, 201–208 (1995)CrossRef Nord, E.: The person trade-off approach to valuing health care programs. Med. Dec. Making 15, 201–208 (1995)CrossRef
30.
Zurück zum Zitat Ubel, P., Loewenstein, G., Scanlon, D., Kamlet, M.: Individual utilities are inconsistent with rationing choices. Med. Dec. Making 16, 108–116 (1996)CrossRef Ubel, P., Loewenstein, G., Scanlon, D., Kamlet, M.: Individual utilities are inconsistent with rationing choices. Med. Dec. Making 16, 108–116 (1996)CrossRef
31.
Zurück zum Zitat Richardson, J.: Critique and some recent contributions to the theory of cost-utility analysis. Working paper 77. Melbourne: Centre for Health Program Evaluation (1997) Richardson, J.: Critique and some recent contributions to the theory of cost-utility analysis. Working paper 77. Melbourne: Centre for Health Program Evaluation (1997)
32.
Zurück zum Zitat Pinto, J.L.P.: Is the person trade-off a valid method for allocating health care resources? Health Econ. 6, 71–81 (1997)CrossRef Pinto, J.L.P.: Is the person trade-off a valid method for allocating health care resources? Health Econ. 6, 71–81 (1997)CrossRef
33.
Zurück zum Zitat Dolan, P., Green, C.: Using the person trade-off approach to examine differences between individual and social values. Health Econ. 7, 307–312 (1998)CrossRefPubMed Dolan, P., Green, C.: Using the person trade-off approach to examine differences between individual and social values. Health Econ. 7, 307–312 (1998)CrossRefPubMed
34.
Zurück zum Zitat Schwarzinger, M., Stouthard, M., Burström, K., Nord, E., et al.: Cross national agreement on disability weights: the European disability weights project. Pop. Health Metrics 1, 9 (2003)CrossRef Schwarzinger, M., Stouthard, M., Burström, K., Nord, E., et al.: Cross national agreement on disability weights: the European disability weights project. Pop. Health Metrics 1, 9 (2003)CrossRef
35.
Zurück zum Zitat Gyrd-Hansen, D.: Investigating the social value of health changes. J. Health Econ. 23, 1101–1116 (2004)CrossRefPubMed Gyrd-Hansen, D.: Investigating the social value of health changes. J. Health Econ. 23, 1101–1116 (2004)CrossRefPubMed
36.
Zurück zum Zitat Dolan, P., Tsuchiya, A.: Health priorities and public preferences: the relative importance of past health experience and future health prospects. J. Health Econ. 24, 703–714 (2005)CrossRefPubMed Dolan, P., Tsuchiya, A.: Health priorities and public preferences: the relative importance of past health experience and future health prospects. J. Health Econ. 24, 703–714 (2005)CrossRefPubMed
37.
Zurück zum Zitat Koopmanschap, M., Stolk, E., Koolman, X.: Dear policy maker: have you made up your mind? Int. J. Technol. Assess. Health Care 26, 198–204 (2010)CrossRefPubMed Koopmanschap, M., Stolk, E., Koolman, X.: Dear policy maker: have you made up your mind? Int. J. Technol. Assess. Health Care 26, 198–204 (2010)CrossRefPubMed
38.
Zurück zum Zitat Lancsar, E., Wildman, J., Donaldson, C., Ryan, M., Baker, R.: Deriving distributional weights for QALYs through discrete choice experiments. J. Health Econ. 30, 466–478 (2011)CrossRefPubMed Lancsar, E., Wildman, J., Donaldson, C., Ryan, M., Baker, R.: Deriving distributional weights for QALYs through discrete choice experiments. J. Health Econ. 30, 466–478 (2011)CrossRefPubMed
39.
Zurück zum Zitat Rosser, R., Kind, P.: A scale of valuations of health states: is there a social consensus? Int J Epidem 7, 347–358 (1978)CrossRef Rosser, R., Kind, P.: A scale of valuations of health states: is there a social consensus? Int J Epidem 7, 347–358 (1978)CrossRef
40.
Zurück zum Zitat Nord, E.: Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J. Health Econ. 25, 170–172 (2006)CrossRefPubMed Nord, E.: Severity of illness and priority setting: worrisome lack of discussion of surprising finding. J. Health Econ. 25, 170–172 (2006)CrossRefPubMed
41.
Zurück zum Zitat Dolan, P., Tsuchyia, A.: Severity of illness and priority setting: worrisome criticism of inconvenient finding? J. Health Econ. 25, 173–174 (2006)CrossRef Dolan, P., Tsuchyia, A.: Severity of illness and priority setting: worrisome criticism of inconvenient finding? J. Health Econ. 25, 173–174 (2006)CrossRef
42.
Zurück zum Zitat Rand-Hendriksen, K., Augestad, L., Dahl, F., Kristiansen, I.S., et al.: A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Med. Dec. Making 32, 569–577 (2012)CrossRef Rand-Hendriksen, K., Augestad, L., Dahl, F., Kristiansen, I.S., et al.: A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Med. Dec. Making 32, 569–577 (2012)CrossRef
43.
Zurück zum Zitat Borge, O.M.: The use of health economics methods at the Norwegian Medicine Agency 2001–2009. Master degree dissertation. Oslo: University of Oslo (2011) Borge, O.M.: The use of health economics methods at the Norwegian Medicine Agency 2001–2009. Master degree dissertation. Oslo: University of Oslo (2011)
44.
Zurück zum Zitat Dolan, P., Cookson, R.: Measuring preferences over the distribution of health benefits. University of York, Mimeo (1998) Dolan, P., Cookson, R.: Measuring preferences over the distribution of health benefits. University of York, Mimeo (1998)
45.
Zurück zum Zitat Bleichrodt, H., Doctor, J., Stolk, E.: A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J. Health Econ. 24, 655–678 (2005)CrossRefPubMed Bleichrodt, H., Doctor, J., Stolk, E.: A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis. J. Health Econ. 24, 655–678 (2005)CrossRefPubMed
46.
Zurück zum Zitat Ottersen, T.: Life time QALY prioritarianism in priority setting. J. Med. Ethics 39, 175–180 (2013)CrossRefPubMed Ottersen, T.: Life time QALY prioritarianism in priority setting. J. Med. Ethics 39, 175–180 (2013)CrossRefPubMed
47.
Zurück zum Zitat Daniels, N.: Just health care. Cambridge University Press, Cambridge (1985)CrossRef Daniels, N.: Just health care. Cambridge University Press, Cambridge (1985)CrossRef
48.
Metadaten
Titel
Transforming EQ-5D utilities for use in cost–value analysis of health programs
verfasst von
Erik Nord
Rune Johansen
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 3/2015
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0576-6

Weitere Artikel der Ausgabe 3/2015

The European Journal of Health Economics 3/2015 Zur Ausgabe